LifeMD(US:LFMD) Prnewswireยท2025-09-12 12:45Core Viewpoint - LifeMD, Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 7, 2025, and August 5, 2025, impacting investors adversely [1][2]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements regarding LifeMD's competitive position and recklessly raised the company's 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and related to obesity treatment drugs [2]. - The allegations suggest that the defendants' statements about LifeMD's business operations and prospects were materially false and misleading, lacking a reasonable basis during the relevant times [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until October 25, 2025, to request the Court to appoint them as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders over the past 20 years and is recognized as one of the top securities litigation firms in the United States [4].